Skip to main content
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: Am J Kidney Dis. 2018 Mar 27;72(1):30–41. doi: 10.1053/j.ajkd.2017.12.012

Figure 2. Eligibility, randomization and follow-up.

Figure 2

There were 64 intervention and 74 control participants who had electronic adherence data available for analysis. Participants who declined to use the electronic pillbox were permitted to remain in the study and followed the same study procedures as patients using the pillbox, except that those in the intervention group could not receive dose reminders from the pillbox, nor were they able to review their adherence data with the coach.